Zum Inhalt der Seite gehen
Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but they now appear to be in decline.

Growth of XEC.* has continued, reaching 37% recently.

#COVID19 #Global #DeFLuQE #XEC
🧵

#COVID19 #global #defluqe #xec
Mike Honey
XEC.* variants show a steady growth advantage of 2.1% per day (14,7% per week) over the dominant DeFLuQE variants. That predicts a crossover in early December.
🧵

⇧